Results of a study funded by PCRF have shown how ‘machine learning’, a branch of artificial intelligence, has the potential to identify which people are more likely to develop pancreatic cancer up to two years before they are diagnosed.
The All-Party Parliamentary Group (APPG) on pancreatic cancer has published a report highlighting the impact of the Covid-19 pandemic on pancreatic cancer services across the country, including diagnosis, treatment and care of patients.
New research, building directly on a previous study funded by PCRF, has found a possible way to target one of the factors that makes pancreatic cancer so aggressive: pancreatic cancer stem cells.
The UK’s national tissue bank for pancreatic diseases is open for applications from any UK-based researchers needing samples of blood, urine and saliva to aid their research.
PCRF has accepted an invitation to be a partner in a research programme that will treat 75 patients with locally advanced pancreatic cancer with the latest high-tech radiotherapy technology.
A pilot study funded by PCRF has shown that by analysing electronic health records with sophisticated computer modelling techniques, it is possible to identify people at risk of developing pancreatic cancer up to 20 months before their diagnosis.
We’re keen to support early career researchers who have chosen to focus on pancreatic cancer, such as PhD student Lavanya Sivapalan from Queen Mary University of London, who carries out innovative research into liquid biopsies.
The foot-and-mouth-disease virus is helping scientists to tackle pancreatic cancer, in new research funded by PCRF. (Image credit: CRUK)
Since losing her husband Gareth, aged just 39, to pancreatic cancer in June 2019, Nichole Jones has been taking every opportunity to raise awareness of the disease, as well as fundraising for PCRF in Gareth’s memory.
Huge congratulations to Abigail Coetzee - now DR Abigail Coetzee - who has been awarded her PhD.